[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@monaco_biotech Monaco

Several biopharmaceutical companies have recently made announcements regarding clinical trials, partnerships, and financial offerings. Notably, companies such as Atai Life Sciences, Praxis Precision Medicines, and Rapt Therapeutics have announced public offerings, while others like Summit Therapeutics and Regeneron have shared updates on their oncology portfolios and pipeline advancements. Additionally, companies like Viridian Therapeutics and Cargo Therapeutics have made announcements regarding public offerings and acquisitions.

Engagements: XXXXX #

X Week XXXXXX +16%
X Month XXXXXXX -XX%
X Months XXXXXXXXX +160%
X Year XXXXXXXXX +39%

Mentions: XX #

X Week XXX -XX%
X Month XXX -XX%
X Months XXXXX +46%
X Year XXXXX +13%

Followers: XXXXX #

X Week XXXXX +0.59%
X Month XXXXX +3.40%
X Months XXXXX +40%
X Year XXXXX +65%

CreatorRank: XXXXXXX #

Social Influence

Social category influence countries XXXXX% stocks XXXX% finance XXXX% cryptocurrencies XXX% currencies XXXX% technology brands XXXX%

Social topic influence announces #184, $fulc #8, $idya 3.14%, business 2.52%, $kymr #5, kymera #3, $tara #40, $immx #12, $srpt #5, $onc #16

Top accounts mentioned or mentioned by @threadanddoc @craigster771 @seedy19tron @biotechport @j_cucinella @financebully @karensmithfl @saicharanaitha @joserestonva @nickblasio @oncinvestor @rezfszubagoly @justiceforb_md @ltbioinvestor @amaymd @snupsnus @persimmonti @aaronrosenblum5 @avidresearch @justiceforbmd

Top Social Posts

Top posts by engagements in the last XX hours

"$ONC BeOne Medicines Announces Third Quarter 2025 Financial Results and Business Updates - ONC BioPharmCatalyst"
X Link 2025-11-06T11:04Z 6175 followers, 1217 engagements

"Will they do the same nonsense with $BLTE as they did with $INBX and bid up where there is nothing to bid up"
X Link 2025-12-02T11:58Z 6175 followers, 1715 engagements

"$RAPP Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219's Clinical Response in Patients with Focal Onset Seizures BioPharmCatalyst"
X Link 2025-12-05T14:19Z 6175 followers, 1088 engagements

"Brief recap of my long tickets today. All sold with data spike today: $IMMX +11% 📈 $FULC +62% 📈 $DYN +15% 📈 $GPCR +150% 📈 * $WVE +158% 📈 $TERN +35% 📈 * Unfortunately sold a little too early. I'm not a fan of having too many stocks in my longterm port so I'm waiting for the financings and then picking out 1-2 gems. $GPCR is definitely one of them"
X Link 2025-12-08T20:45Z 6175 followers, 4984 engagements

"$TERN @ $XXXXX Terns Announces Pricing of Upsized $XXX Million Public Offering BioPharmCatalyst"
X Link 2025-12-10T09:14Z 6175 followers, 1469 engagements

"$RYTM Rhythm Pharmaceuticals to Announce Preliminary Data from Exploratory Phase X Trial Evaluating Setmelanotide in Prader-Willi Syndrome BioPharmCatalyst"
X Link 2025-12-10T21:04Z 6175 followers, 5644 engagements

"$ONC BeOne Medicines' Sonrotoclax Granted Breakthrough Therapy Designation by U.S. FDA - ONC BioPharmCatalyst"
X Link 2025-10-13T10:04Z 6172 followers, 1404 engagements

"$COGT I have added to my existing long-term position. I am deeply convinced that this stock is a candidate for a buyout that at least 2-3 big pharma will be fighting over. Thanks for the dips. I will continue to accumulate ✌🏻🤑"
X Link 2025-12-09T18:20Z 6175 followers, 11.1K engagements

"Darwin Global strikes again 🔥 It looks like I need to reconsider my opinion on $BLTE"
X Link 2025-12-10T23:27Z 6175 followers, 10.8K engagements

"$KYMR Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621 a First-in-Class Oral STAT6 Degrader for the Treatment of Atopic Dermatitis BioPharmCatalyst"
X Link 2025-12-11T12:09Z 6175 followers, XXX engagements

"$RYTM Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase X Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome BioPharmCatalyst"
X Link 2025-12-11T12:42Z 6175 followers, 1280 engagements

"$ABOS Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration Option and License Agr. - ABOS BioPharmCatalyst"
X Link 2025-07-15T11:16Z 6163 followers, XXX engagements

"$ASRT Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN (clobazam) O. - ASRT BioPharmCatalyst"
X Link 2025-09-15T13:03Z 6163 followers, 1146 engagements

"$NBIX Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Es. - NBIX BioPharmCatalyst"
X Link 2025-10-06T12:33Z 6163 followers, 3237 engagements

"$IDYA Much better picture now for my position. Keep going 💪🏻😃 Now only $CRNX is lagging behind"
X Link 2025-10-28T14:52Z 6163 followers, 3247 engagements

"$IDYA IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update - IDYA BioPharmCatalyst"
X Link 2025-11-04T11:02Z 6163 followers, 1232 engagements

"$RPRX $ALNY Royalty Pharma Acquires Royalty Interest in Alnylam's AMVUTTRA for $XXX Million from Blackstone Life. - RPRX BioPharmCatalyst"
X Link 2025-11-04T12:18Z 6173 followers, 3872 engagements

"$PRTA Prothena Reports Third Quarter 2025 Financial Results and Business Highlights - PRTA BioPharmCatalyst"
X Link 2025-11-06T21:36Z 6172 followers, XXX engagements

"$PRTA Prothena Highlights Phase X Data for Coramitug (Formerly PRX004) Published in Circulation Official. - PRTA BioPharmCatalyst"
X Link 2025-11-11T14:14Z 6172 followers, 1934 engagements

"$ORKA Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ORKA BioPharmCatalyst"
X Link 2025-11-12T21:07Z 6163 followers, XXX engagements

"$CGON CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates - CGON BioPharmCatalyst"
X Link 2025-11-14T13:19Z 6163 followers, XXX engagements

"There are definitely no traders with strong nerves in $IMMX 📈📉📈📉 whereas $GUTS and $QNRX are home to diamond hands. Data $IMMX at ASH December X and before that everyone will get FOMO lol"
X Link 2025-11-17T20:03Z 6163 followers, 1979 engagements

"$CELC Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatoli. - CELC BioPharmCatalyst"
X Link 2025-11-17T21:07Z 6164 followers, 1516 engagements

"$VEEV $RHHBF Veeva Announces Expanded Partnership with Roche"
X Link 2025-11-24T12:15Z 6172 followers, 1169 engagements

"$ARWR $SRPT Arrowhead Pharmaceuticals Earns $XXX Million Milestone Payment from Sarepta Therapeutics - SRPT BioPharmCatalyst"
X Link 2025-11-24T12:53Z 6172 followers, 1519 engagements

"$VRCA +11% 📈 pre-market Verrica Pharmaceuticals Announces Private Placement Financing of $XX Million to Retire Debt and Exte. - VRCA BioPharmCatalyst"
X Link 2025-11-24T13:05Z 6163 followers, 1168 engagements

"$MESO Mesoblast Trading Update at Annual General Meeting Highlights Continued Strong Growth in Ryoncil Re. - MESO BioPharmCatalyst"
X Link 2025-11-24T23:43Z 6173 followers, 1210 engagements

"$IDYA IDEAYA Biosciences Announces IND Clearance for IDE034 a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types"
X Link 2025-12-01T11:08Z 6163 followers, 2430 engagements

"$QTTB Q32 Bio Sells Complement Inhibitor ADX-097"
X Link 2025-12-01T12:03Z 6163 followers, 5015 engagements

"$IONS Ionis receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridem. - IONS BioPharmCatalyst"
X Link 2025-12-01T12:05Z 6173 followers, 1067 engagements

"$ALT Altimmune Announces CEO Transition and Succession Plan - ALT BioPharmCatalyst"
X Link 2025-12-01T12:30Z 6161 followers, 1465 engagements

"$JANX Not anymore. Sold at a loss. The word "encouraging" was the signal to run lol 🚩❌"
X Link 2025-12-01T21:42Z 6165 followers, 8731 engagements

"$IONS Ionis receives U.S. FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD) - IONS BioPharmCatalyst"
X Link 2025-12-02T12:15Z 6173 followers, 1072 engagements

"$ABOS Acumen Pharmaceuticals Highlights Enhanced Brain Delivery Technology for Oligomer-Selective Antibod. - ABOS BioPharmCatalyst"
X Link 2025-12-02T13:22Z 6171 followers, 1059 engagements

"$FULC Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Po. - FULC BioPharmCatalyst"
X Link 2025-12-02T14:13Z 6167 followers, 2503 engagements

"$AZN Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-. - AZN BioPharmCatalyst @avidresearch"
X Link 2025-12-02T14:18Z 6172 followers, 1631 engagements

"$RPRX $DNLI Denali Therapeutics and Royalty Pharma Announce $XXX Million Royalty Funding Agreement BioPharmCatalyst"
X Link 2025-12-04T12:17Z 6173 followers, 1590 engagements

"$IDYA IDE034 a Bispecific ADC Licensed by Biocytogen to IDEAYA Receives FDA IND Clearance BioPharmCatalyst"
X Link 2025-12-05T00:05Z 6164 followers, 1740 engagements

"@KarenSmithFL $ALNT $TER also great"
X Link 2025-12-05T00:52Z 6165 followers, XXX engagements

"$XENE Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 BioPharmCatalyst"
X Link 2025-12-05T14:19Z 6164 followers, XXX engagements

"$FULC Fulcrum Therapeutics Announces Positive Initial Results from the XX mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting BioPharmCatalyst"
X Link 2025-12-06T22:50Z 6172 followers, 4000 engagements

"$SLS SELLAS Life Sciences Presents Positive Phase X Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025 BioPharmCatalyst"
X Link 2025-12-07T23:05Z 6164 followers, 2566 engagements

"$SATS frisky 🔥 Not a bio but it might be worth risking a trade"
X Link 2025-12-08T02:00Z 6164 followers, 1161 engagements

"@biopharmacaster Patience. People have to realize these amazing results $DYN. $SRPT should be toast on this news"
X Link 2025-12-08T11:46Z 6172 followers, 1009 engagements

"$AGIO Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia BioPharmCatalyst"
X Link 2025-12-08T12:03Z 6172 followers, 1700 engagements

"$KYMR Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis BioPharmCatalyst"
X Link 2025-12-08T12:04Z 6167 followers, 1594 engagements

"$RXRX Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks"
X Link 2025-12-08T12:33Z 6161 followers, 1123 engagements

"$MIRM Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics Expanding Global Leadership in Rare Disease BioPharmCatalyst"
X Link 2025-12-08T13:09Z 6167 followers, 1202 engagements

"$SABS SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management BioPharmCatalyst"
X Link 2025-12-08T13:11Z 6163 followers, 1240 engagements

"$PRAX Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies BioPharmCatalyst"
X Link 2025-12-08T13:14Z 6163 followers, 1592 engagements

"$CRVS Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial BioPharmCatalyst"
X Link 2025-12-08T15:37Z 6173 followers, 4430 engagements

"$KYMR Kymera Therapeutics Announces Proposed Public Offering BioPharmCatalyst"
X Link 2025-12-08T21:03Z 6163 followers, 2202 engagements

"$FULC Fulcrum Therapeutics Announces Proposed $XXXXX Million Public Offering of Common Stock BioPharmCatalyst"
X Link 2025-12-08T21:04Z 6172 followers, 1005 engagements

"@lame_karma Congrats. Now that the binaries are done it's time to see who has the most buyout potential. Not an easy task but I see $GPCR at the top of the list. $COGT too. And I agree that $FULC also belong in the inner circle. Too many good names at the moment"
X Link 2025-12-08T23:35Z 6164 followers, XXX engagements

"$VTGN Vistagen Completes PALISADE-3 Phase X Public Speaking Challenge Study for the Acute Treatment of Soc. - VTGN BioPharmCatalyst"
X Link 2025-11-03T13:30Z 6173 followers, 1761 engagements

"$KYMR @ $XXXXX Kymera Therapeutics Announces Pricing of Upsized $XXX Million Public Offering BioPharmCatalyst"
X Link 2025-12-10T09:15Z 6173 followers, 1687 engagements

"$FULC @ $XXXXX Fulcrum Therapeutics Announces Pricing of Upsized $XXXXX Million Public Offering of Common Stock and Pre-Funded Warrants BioPharmCatalyst"
X Link 2025-12-10T12:53Z 6173 followers, 1544 engagements

"$NBIX #fail Neurocrine Biosciences Provides Update on Phase X Study of NBI-1070770 in Adults with Major Depressi. - NBIX BioPharmCatalyst"
X Link 2025-11-10T21:10Z 6173 followers, 10.8K engagements

"@doepke_michel And don't forget that we are also waiting for the price reactions of $IMMX $FULC from the Ash data 😅"
X Link 2025-12-08T09:12Z 6173 followers, XXX engagements

"$LXEO Added today new trading position for data event soon"
X Link 2025-12-09T18:37Z 6172 followers, 3465 engagements

"$APGE Easy peasy 47$ to 63$ 📈🤌🏻"
X Link 2025-11-11T18:17Z 6174 followers, 4145 engagements

"$TARA Conference call and live webcast at 8:30 a.m. ET on Wednesday November XX 2025 📌 Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X STA. - TARA BioPharmCatalyst"
X Link 2025-11-18T21:32Z 6174 followers, 2310 engagements

"$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoin. - TARA BioPharmCatalyst"
X Link 2025-11-19T13:08Z 6174 followers, 2489 engagements

"$TARA Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X ADV. - TARA BioPharmCatalyst"
X Link 2025-12-01T21:29Z 6174 followers, 2058 engagements

"$TARA Protara Announces Proposed Public Offering BioPharmCatalyst"
X Link 2025-12-04T21:26Z 6174 followers, 1084 engagements

"$IDYA IDEAYA Biosciences Announces IND Submission for IDE574 a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers BioPharmCatalyst"
X Link 2025-12-10T11:20Z 6174 followers, 1722 engagements

"Who is actually selling $FULC just because the offer price is $XXXXX In a few days many will be grateful to the sellers jmho. Watch and learn 🤓"
X Link 2025-12-10T13:37Z 6175 followers, 3222 engagements

"@threadanddoc LOL I agree its a pretty wildcard"
X Link 2025-12-10T23:30Z 6175 followers, XXX engagements

"@threadanddoc Yep. Now that $VRNA $MRUS $CDTX are gone this seems to be a new placeholder. There will certainly be 1-2 more to follow"
X Link 2025-12-10T23:36Z 6175 followers, XXX engagements

"Until now I was bothered by the fact that it is an Asian company. I always have my doubts about credibility. But the YTD performance proves them right. And we know that Darwin Global has a track record that is quite legendary. It is a quality check in itself when Darwin purchases this massive amount of shares jmho"
X Link 2025-12-11T00:19Z 6175 followers, XXX engagements

"$SRPT Sarepta Therapeutics Announces Refinancing of Approximately $XXX Million of XXXX% Convertible Senior Notes due 2027 BioPharmCatalyst"
X Link 2025-12-11T12:14Z 6175 followers, 1651 engagements

"$ATOS +17% 📈 pre-market Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy BioPharmCatalyst"
X Link 2025-12-11T13:11Z 6175 followers, 1132 engagements

"$ABSI Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201 Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization BioPharmCatalyst"
X Link 2025-12-11T13:15Z 6175 followers, 1164 engagements